David Leather

1.4k citations

41 papers · 942 indexed · h-index 14

Impact in

Emergency Medicine top 2%
- HIV-related health complications and treatments
Virology top 5%

Papers in ⓘ

Pulmonary and Respiratory Medicine 26
- Chronic Obstructive Pulmonary Disease (COPD) Research 18
- Respiratory and Cough-Related Research 14
- Inhalation and Respiratory Drug Delivery 9
Physiology 21
- Asthma and respiratory diseases 21

Co-authors: Ashley Woodcock (13 shared papers)Nawar Diar Bakerly (13 shared papers)John P. New (10 shared papers)Jørgen Vestbo (10 shared papers)Martin Gibson (5 shared papers)Henrik Svedsäter (12 shared papers)Adriano Lazzarin (2 shared papers)José Ramón Arribas (1 shared paper)
Journals: npj Primary Care Respiratory Medicine (4 papers)Respiratory Medicine (4 papers)Thorax (3 papers)Respiratory Research (2 papers)Primary Care Respiratory Journal (2 papers)
Partner nations: United Kingdom United States Germany

In The Last Decade

David Leather

38 papers receiving 925 citations

Peers

Countries citing papers authored by David Leather

Since Specialization

Citations

This map shows the geographic impact of David Leather's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Leather with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Leather more than expected).

Fields of papers citing papers by David Leather

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Leather. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Leather. The network helps show where David Leather may publish in the future.

Co-authors

The 25 scholars most cited alongside David Leather, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Leather Line = papers co-authored together David Leather links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Comparison of Changes in Bone Density and Turnover with Abacavir‐Lamivudine versus Tenofovir‐Emtricitabine in HIV‐Infected Adults: 48‐Week Results from the ASSERT Study Clinical Infectious Diseases ·Hans‐Jürgen Stellbrink, Chloe Orkin, José Ramón Arribas, Juliet Compston, Jan Gerstoft, Eric Van Wijngaerden, Adriano Lazzarin, Giuliano Rizzardini, Herman G. Sprenger, John S. Lambert, Gunta Stūre, David Leather, Sara Hughes, Patrizia Zucchi, Helen Pearce	2010	315
2	Effectiveness of Fluticasone Furoate–Vilanterol for COPD in Clinical Practice New England Journal of Medicine ·Jørgen Vestbo, David Leather, Nawar Diar Bakerly, John P. New, Martin Gibson, Sheila McCorkindale, Susan Collier, Jodie Crawford, Lucy Frith, Catherine Harvey, Henrik Svedsäter, Ashley Woodcock	2016	138
3	Obtaining real-world evidence: the Salford Lung Study Thorax ·John P. New, Nawar Diar Bakerly, David Leather, Ashley Woodcock	2014	66
4	Effects of switching from a metered dose inhaler to a dry powder inhaler on climate emissions and asthma control: post-hoc analysis Thorax ·Ashley Woodcock, Christer Janson, Jamie Rees, Lucy Frith, Magnus Löfdahl, Alison Moore, Martin Hedberg, David Leather	2022	59
5	Moving towards a Treatable Traits model of care for the management of obstructive airways diseases Respiratory Medicine ·Àlvar Agustí, Neil Barnes, Álvaro A. Cruz, Peter G. Gibson, Liam G. Heaney, Hiromasa Inoue, David Leather, Fernando J. Martínez, Vanessa M. McDonald, John Oppenheimer, Alberto Papi, Ian Pavord, Mike Thomas, Samantha Walker, Louisa Yates	2021	42
6	The Salford Lung Study protocol: a pragmatic, randomised phase III real-world effectiveness trial in asthma BMC Pulmonary Medicine ·Ashley Woodcock, Nawar Diar Bakerly, John P. New, Martin Gibson, Wei Wu, Jørgen Vestbo, David Leather	2015	31
7	The Salford Lung Study protocol: a pragmatic, randomised phase III real-world effectiveness trial in chronic obstructive pulmonary disease Respiratory Research ·Nawar Diar Bakerly, Ashley Woodcock, John P. New, Martin Gibson, Wei Wu, David Leather, Jørgen Vestbo	2015	30
8	Improving primary care management of asthma: do we know what really works? npj Primary Care Respiratory Medicine ·Monica Fletcher, Ioanna Tsiligianni, Janwillem Kocks, Andrew Cave, Chunhua Chi, Jaime Correia de Sousa, Miguel Román-Rodríguez, Mike Thomas, Péter Kardos, Carol Stonham, Ee Ming Khoo, David Leather, Thys van der Molen	2020	27
9	Effectiveness versus efficacy trials in COPD: how study design influences outcomes and applicability European Respiratory Journal ·Ashley Woodcock, I. Boucot, David Leather, Jodie Crawford, Susan Collier, Nawar Diar Bakerly, Emma Hilton, Jørgen Vestbo	2018	27
10	Putting patients in control of data from electronic health records BMJ ·John P. New, David Leather, Nawar Diar Bakerly, John P. McCrae, Martin Gibson	2018	23
11	Utility of COPD Assessment Test (CAT) in primary care consultations: a randomised controlled trial Primary Care Respiratory Journal ·Kevin Gruffydd‐Jones, Helen Marsden, Steve Holmes, Péter Kardos, R. Escamilla, Roberto Dal Negro, June Roberts, Gilbert Nadeau, Mathieu Vasselle, David Leather, Paul Jones	2013	19
12	Patient-reported outcomes with initiation of fluticasone furoate/vilanterol versus continuing usual care in the Asthma Salford Lung Study Respiratory Medicine ·Henrik Svedsäter, Rupert Jones, Nick Bosanquet, Loretta Jacques, James Lay‐Flurrie, David Leather, Jørgen Vestbo, Susan Collier, Ashley Woodcock	2018	14
13	Effectiveness of fluticasone furoate/vilanterol versus fluticasone propionate/salmeterol on asthma control in the Salford Lung Study Journal of Asthma ·Loretta Jacques, Nawar Diar Bakerly, John P. New, Henrik Svedsäter, James Lay‐Flurrie, David Leather	2018	14
14	High-dose inhaled corticosteroids and add-on therapy use in adults with asthma in the UK in 2003: an observational study Primary Care Respiratory Journal ·Mike Thomas, David Leather, David Price	2006	13
15	Salford Lung Study in chronic obstructive pulmonary disease (SLS COPD): follow-up interviews on patient-centred outcomes npj Primary Care Respiratory Medicine ·Lynda Doward, Henrik Svedsäter, Diane Whalley, Rebecca J. Crawford, David Leather, James Lay‐Flurrie, Nick Bosanquet	2017	13
16	Once-daily fluticasone furoate/vilanterol 100/25 mcg versus twice daily combination therapies in COPD – mixed treatment comparisons of clinical efficacy Respiratory Research ·G. Stynes, Henrik Svedsäter, Jaro Wex, Sally Lettis, David Leather, E Castelnuovo, Michelle A. Detry, Scott Berry	2015	13
17	Evaluation and quantification of treatment preferences for patients with asthma or COPD using discrete choice experiment surveys Respiratory Medicine ·Henrik Svedsäter, David Leather, Terence J. Robinson, Helen Doll, Beenish Nafees, Lisa Bradshaw	2017	12
18	Clinical effectiveness of once-daily fluticasone furoate/umeclidinium/vilanterol in usual practice: the COPD INTREPID study design ERJ Open Research ·Sally Worsley, Neil G. Snowise, David Halpin, Dawn Midwinter, Afisi Ismaila, Elaine Irving, Leah B. Sansbury, Maggie Tabberer, David Leather, Chris Compton	2019	11
19	Once-daily fluticasone furoate/vilanterol versus twice daily combination therapies in asthma–mixed treatment comparisons of clinical efficacy PubMed ·Henrik Svedsäter, G. Stynes, Jaro Wex, Lucy Frith, David Leather, E Castelnuovo, Michelle A. Detry, Scott Berry	2016	10
20	Study of Once-Daily Versus Twice-Daily Fosamprenavir plus Ritonavir Administered with Abacavir/Lamivudine Once Daily in Antiretroviral-Naïve HIV-1–Infected Adult Subjects HIV Clinical Trials ·G. Carosi, Adriano Lazzarin, Hans‐Juergen Stellbrink, Graeme Moyle, Sorin Rugină, Schlomo Staszewski, Naomi Givens, Lisa Ross, Catherine Granier, Mounir Ait‐Khaled, David Leather, W. Garrett Nichols	2009	10

About David Leather

David Leather is a scholar working on Pulmonary and Respiratory Medicine, Physiology, Economics and Econometrics, Cardiology and Cardiovascular Medicine and Epidemiology, having authored 41 papers that have together received 942 indexed citations. Recurring topics across this work include Asthma and respiratory diseases (21 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (18 papers), Respiratory and Cough-Related Research (14 papers), Inhalation and Respiratory Drug Delivery (9 papers), Heart Failure Treatment and Management (4 papers), Chronic Disease Management Strategies (4 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers) and Behavioral Health and Interventions (2 papers). The work is most often cited by research in Emergency Medicine (264 citations), Virology (112 citations), Orthopedics and Sports Medicine (137 citations), Family Practice (30 citations) and Pulmonary and Respiratory Medicine (368 citations). David Leather has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Ashley Woodcock, Nawar Diar Bakerly, John P. New, Jørgen Vestbo, Martin Gibson, Henrik Svedsäter, Adriano Lazzarin, José Ramón Arribas, John S. Lambert and Chloe Orkin. Their work appears in journals such as npj Primary Care Respiratory Medicine, Respiratory Medicine, Thorax, Respiratory Research and Primary Care Respiratory Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact